Massimo Menga
Impact in
-
- Lymphoma Diagnosis and Treatment
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 6
-
- Ovarian cancer diagnosis and treatment 2
- Co-authors
- Francesca P. Giunta (2 shared papers)Roberto Passera (4 shared papers)Giorgio Limerutti (1 shared paper)Luigi Rigacci (2 shared papers)G Bisi (1 shared paper)Marco Ladetto (3 shared papers)Marilena Bellò (3 shared papers)Barbara Botto (1 shared paper)
In The Last Decade
Massimo Menga
13 papers receiving 328 citations
Peers
Comparison fields: 5 of 36
- Pathology and Forensic Medicine 248
- Neurology 84
- Radiology, Nuclear Medicine and Imaging 104
- Oncology 80
- Genetics 29
Countries citing papers authored by Massimo Menga
This map shows the geographic impact of Massimo Menga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Menga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Menga more than expected).
Fields of papers citing papers by Massimo Menga
This network shows the impact of papers produced by Massimo Menga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Menga. The network helps show where Massimo Menga may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Menga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 182 | |
| 2 | 2018 | 57 | |
| 3 | 2019 | 37 | |
| 4 | 2018 | 22 | |
| 5 | 2009 | 10 | |
| 6 | 2017 | 7 | |
| 7 | 2023 | 5 | |
| 8 | Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use? | 2015 | 3 |
| 9 | 2022 | 3 | |
| 10 | 1997 | 2 | |
| 11 | 2014 | 2 | |
| 12 | 2010 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2022 | 0 |
About Massimo Menga
Massimo Menga is a scholar working on Pathology and Forensic Medicine, Reproductive Medicine, Ophthalmology, Genetics and Neurology, having authored 14 papers that have together received 332 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Sarcoma Diagnosis and Treatment (2 papers), Ovarian cancer diagnosis and treatment (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Ocular Diseases and Behçet’s Syndrome (1 paper), Frequency Control in Power Systems (1 paper), Antenna Design and Analysis (1 paper) and Intraocular Surgery and Lenses (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (248 citations), Neurology (84 citations), Radiology, Nuclear Medicine and Imaging (104 citations), Oncology (80 citations) and Genetics (29 citations). Massimo Menga has collaborated with scholars based in Italy, France and Australia. Frequent co-authors include Francesca P. Giunta, Roberto Passera, Giorgio Limerutti, Luigi Rigacci, G Bisi, Marco Ladetto, Marilena Bellò, Barbara Botto, Benedetta Puccini and Annalisa Chiappella. Their work appears in journals such as Blood, Hematological Oncology, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Research and Ophthalmologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.